症状相关中断的改善与短效β激动剂在哮喘中的使用天数减少有关。

IF 3.1 3区医学 Q1 PRIMARY HEALTH CARE

NPJ Primary Care Respiratory Medicine Pub Date : 2022-09-02 DOI:10.1038/s41533-022-00299-3

Leanne Kaye, Vy Vuong, Meredith A Barrett, Elroy Boers, Theresa Guilbert

引用次数: 0

摘要

大量的间接医疗费用与不受控制的哮喘有关，包括生产力损失。使用短效β受体激动剂(SABA)的天数与工作、家庭和学校的症状相关中断有关。数字自我管理平台可能支持更短的SABA药物使用时间，并可能减少与症状相关的中断。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

Improvement in symptom-related disruptions is associated with fewer days of short-acting beta-agonist use in asthma.

查看原文本刊更多论文

Improvement in symptom-related disruptions is associated with fewer days of short-acting beta-agonist use in asthma.

Significant indirect healthcare costs are related to uncontrolled asthma, including productivity loss. Days with short-acting beta-agonist (SABA) use is associated with symptom-related disruptions at work, home, and school. Digital self-management platforms may support fewer days with SABA medication use and may reduce symptom-related disruptions.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

NPJ Primary Care Respiratory Medicine PRIMARY HEALTH CARE-RESPIRATORY SYSTEM

CiteScore

5.50

自引率

6.50%

发文量

审稿时长

10 weeks

期刊介绍： npj Primary Care Respiratory Medicine is an open access, online-only, multidisciplinary journal dedicated to publishing high-quality research in all areas of the primary care management of respiratory and respiratory-related allergic diseases. Papers published by the journal represent important advances of significance to specialists within the fields of primary care and respiratory medicine. We are particularly interested in receiving papers in relation to the following aspects of respiratory medicine, respiratory-related allergic diseases and tobacco control: epidemiology prevention clinical care service delivery and organisation of healthcare (including implementation science) global health.